The Effect of Renal Dysfunction on Circulating Sclerostin Level in Patients with Type 2 Diabetes

Objective. Sclerostin is a Wnt inhibitor produced specifically by osteocytes. However, it is not currently clear whether renal dysfunction has an effect on circulating sclerostin level in patients with type 2 diabetes. The aim of the study was to evaluate this relationship. Design and Patients. We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Se Hwa, Yoon, Soo Young, Lim, Sung-Kil, Rhee, Yumie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099222/
https://www.ncbi.nlm.nih.gov/pubmed/25053944
http://dx.doi.org/10.1155/2014/715908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099222/
https://www.ncbi.nlm.nih.gov/pubmed/25053944
http://dx.doi.org/10.1155/2014/715908

Ejemplares similares